Fabio Rigamonti1, MD; Gregor Fahrni2, MD; Micha Maeder3, MD; Stéphane Cook4, MD; Daniel Weilenmann3, MD; Peter Wenaweser5, MD; Christian Röthlisberger6, MD; Roberto Corti7, MD; Hans Rickli3, MD; Christoph Kaiser8, MD; Marco Roffi1*, MD; on behalf of the Working Group for Interventional Cardiology of the Swiss Society of Cardiology
1. Division of Cardiology, Geneva University Hospitals, Geneva, Switzerland; 2. Oxford Heart Centre, The John Radcliffe Hospital, Oxford University Hospitals, Oxford, United Kingdom; 3. Division of Cardiology, St. Gallen County Hospital, St. Gallen, Switz
In 2015, Switzerland had a population of 8.3 million inhabitants. Since the first coronary angioplasty performed by Andreas Grüntzig in Zurich in 1977, the number of percutaneous procedures has steadily increased. The aim of